Sherry Rogers
Adult Health · Venice, FLNPI 1083996706
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $14,914 of the $19,830 with a category attached, or 75.2%. Intuitive Surgical accounts for 75.2% of it on its own, with 30 other manufacturers making up the rest. Among adult health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $64.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$15K
- Pfizer$748
- AbbVie$726
- Astellas Pharma US Inc$439
- GSK$425
- AstraZeneca$354
- plus $2K from 25 others
What the payments were for
- Travel & lodging$14,91475%
- Food & beverage$4,81624%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 52 | $14,914 |
| Pfizer | 37 | $748 |
| AbbVie | 43 | $726 |
| Astellas Pharma US Inc | 18 | $439 |
| GSK | 36 | $425 |
| AstraZeneca | 14 | $354 |
| Amgen | 17 | $323 |
| Abbott | 12 | $271 |
| Novo Nordisk | 13 | $255 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $225 |
| Lilly USA, LLC | 8 | $166 |
| Bayer | 6 | $155 |
| Exact Sciences | 4 | $108 |
| Boston Scientific | 3 | $86 |
| Dexcom, Inc. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Boehringer Ingelheim | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Radius Health, Inc. | 3 | $43 |
| Novartis | 2 | $39 |
| Mylan Specialty L.p. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Organon | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Almatica Pharma LLC | 1 | $18 |
| Lucid Diagnostics Inc. | 1 | $18 |
| Merck | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$14,528
How this compares
$19,830 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 93 | $102,079 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $69,715 |
| OzempicSemaglutide | 37 | $57,050 |
| MounjaroTirzepatide | 19 | $35,117 |
| XareltoRivaroxaban | 27 | $26,476 |
| MyrbetriqMirabegron | 21 | $24,702 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $19,950 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $11,997 |
| PremarinEstrogens, Conjugated | 13 | $6,213 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 28 | $6,176 |
| Omeprazole | 233 | $3,843 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 158 | $3,766 |
| Rosuvastatin Calcium | 233 | $3,724 |
| Ipratropium Bromide | 83 | $3,642 |
| Atorvastatin Calcium | 403 | $3,420 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Premarin, Paxlovid | $748 | $111,057141 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Shingrix | $425 | $107,838127 claims |
| Novo NordiskOzempic | $255 | $57,05037 claims |
| Lilly USA, LLCMounjaro | $166 | $35,11719 claims |
| Astellas Pharma US IncMyrbetriq | $439 | $24,70221 claims |
| AbbVieSynthroid | $726 | $1,45945 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Venice
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.